Skip to main content

Inkef — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

48
Companies
$1.3B
Total invested
$28.5M
Avg. check
51
Industries
Biotechnology 11Pharmaceutical 8Health Care 7Therapeutics 7Medical 6Information Technology 4+45 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 48
Calypso Biotech
September 2021

Calypso Biotech is a biotechnology company that developes therapeutics for autoimmune diseases.

Biotechnology · Plan-les-ouates$9.5M Series A
Sentinels
September 2021

Sentinels is an AI-powered transaction monitoring startup.

Artificial Intelligence (AI) · AmsterdamCorporate Round
EclecticIQ
August 2021

EclecticIQ offers threat intelligence, hunting, response technology, and services.

Artificial Intelligence (AI) · Amsterdam$3.5M Venture - Series Unknown
Cardior Pharmaceuticals
August 2021

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

Biopharma · Hanover$75.3M Series B
Happeo
July 2022

Happeo is a next-gen intranet that keeps teams informed, aligned, and productive

Cloud Computing · Helsinki$26.0M Series B
Baserow
July 2022

Open source online database

Database · Zaanstad$5.1M Seed
Provable Markets
July 2026

Provable Markets provides a secure platform for cash and synthetic equity finance trading through its ATS, Aurora.

Finance · New York$8.0M Series B
Castor
July 2021

Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.

Clinical Trials · Amsterdam$45.0M Series B
Aito
June 2023

Aito develops configurable touch-interface chips using Software Enhanced Piezo (SEP) for overlays on glass, metal, plastic, wood, or fabric.

Augmented Reality · Amsterdam$6.5M Venture - Series Unknown
Onward
April 2026

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

Biotechnology · Eindhoven$47.8M Post-IPO Equity
Scenic Biotech
March 2022

Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.

Biometrics · Amsterdam$31.0M Series A
Precirix
March 2022

Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.

Biotechnology · Brussels$88.2M Series B
ChannelEngine
March 2022

ChannelEngine helps brands, wholesalers, and retailers to effectively sell on marketplaces in a fully automated way.

Advertising · Leiden$49.9M Series B
Salvia BioElectronics
May 2025

Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.

Biotechnology · Eindhoven$60.4M Series B
VarmX
February 2025

VarmX B.V. is manufacturing therapeutic proteins to instantaneously restore blood clotting in bleeding patients.

Manufacturing · Leiden$15.8M Venture - Series Unknown
AmbAgon Therapeutics
February 2025

AmbAgon Therapeutics is a developer of cancer molecule therapeutics.

Biotechnology · San Francisco$5.0M Venture - Series Unknown
Draupnir Bio
July 2024

Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.

Biotechnology · Risskov$13.2M Seed
iOnctura
June 2024

iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.

Biotechnology · Genive$85.7M Series B
Urban Sports Club
December 2023

Urban Sports offers a monthly flat rate for all kinds of sports activities in the city.

Fitness · Berlin$104.4M Venture - Series Unknown
Silverflow
November 2023

Silverflow is a payment processing technology company that provides direct card-network access to payment service providers.

Financial Services · Amsterdam$16.3M Series A
NMD Pharma
November 2023

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

Medical · Risskov$81.4M Series B
Anavo Therapeutics
May 2023

Anavo Therapeutics provides therapeutic potential of human phosphatase biology.

Biotechnology · Leiden$9.4M Seed
ViCentra
January 2026

ViCentra has developed an insulin pump for diabetes patients.

Health Care · Utrecht$13.0M Series D
TargED Biopharmaceuticals
December 2025

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.

Biopharma · Utrecht$25.3M Series A

Where Inkef invests

Biotechnology11
Pharmaceutical8
Health Care7
Therapeutics7
Medical6
Information Technology4

About Inkef's portfolio

How many companies has Inkef invested in?

Inkef has invested in 48 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Inkef invest in?

Inkef's top investment sectors include Biotechnology, Pharmaceutical, Health Care, Therapeutics, Medical. The firm invests across 51 different industry categories.

What is Inkef's largest investment?

Among tracked funding rounds, Urban Sports Club received $104.4M in a Venture - Series Unknown round. Inkef's total known invested capital is $1.3B.

What is the average investment size for Inkef?

Inkef's average investment size is $28.5M across its portfolio of 48 companies.

What are Inkef's most recent investments?

Recent Inkef portfolio additions include Calypso Biotech, Sentinels, EclecticIQ, Cardior Pharmaceuticals, Happeo. These companies were founded in 2020 or later.

Reach the founders behind these 48 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →